Table 3.
Blood pressure control and use of antihypertensive medication among CKD patients with hypertension according to level of UACR
| Characteristics |
Overall, n (%, 95% CIs) |
UACR, mg/mmol, n (%, 95% CIs) |
||
|---|---|---|---|---|
|
<3.0 |
≥ 3.0 |
≥3.0 and diabetes |
||
| n = 267 | N = 56 | N = 211 | N = 107 † | |
| BP ≤ 140/90 mm Hg, n (%, 95% CI) |
51 (19.1, 14.6 – 24.3) |
13 (23.2, 13.0 – 36.4) |
38 (18, 13.1 – 23.9) |
20 (18.7, 11.8 – 27.4) |
| BP ≤ 130/80 mm Hg, n (%, 95% CI) |
17 (6.4, 3.8 – 10.0) |
6 (10.7, 4.0 – 21.9) |
11 (5.2, 2.6 – 9.1) |
6 (5.6, 2.1 – 11.8) |
| Use of antihypertensive medications, n (%, 95% CI) | 130 (48.7, 42.6 – 54.9) | 33 (58.9, 45.0 – 71.9) | 97 (46, 39.1 – 52.9) | 54 (50.5, 40.6 – 60.3) |
UACR = Urinary Albumin to Creatinine Ratio; BP = Blood Pressure.
CKD (G3, A2 or worse) is defined as the eGFR < 60 mL/min/1.73 m2 estimated by CKD-EPIPK equation (0.686 × CKD-EPI1.059) or UACR ≥3 mg/mmol.
†Patients with diabetes mellitus and UACR ≥3 mg/mmol along with CKD and hypertension.